Literature DB >> 2311586

An unusual structure of a putative T cell oncogene which allows production of similar proteins from distinct mRNAs.

T Boehm1, J M Greenberg, L Buluwela, I Lavenir, A Forster, T H Rabbitts.   

Abstract

We previously identified a putative T cell oncogene on chromosome 11 near a translocation t(11;14)(p15;q11) in a human T cell tumour. The gene is transcribed from distinct promoters which have unrelated sequences, which occur within close but distinct methylation-free islands and which allow cell specific production of mRNA. The alternative first exons each contain a protein initiation codon from which two species of protein can be made, differing by only a single amino acid. The protein sequence is highly conserved between man and mouse (98%) and the same single codon difference between alternative first exons is also conserved. This is, therefore, a new form of eukaryotic gene organization from which similar proteins can be made from distinct mRNA species.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2311586      PMCID: PMC551746          DOI: 10.1002/j.1460-2075.1990.tb08183.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  25 in total

1.  Hereditary cancer, oncogenes, and antioncogenes.

Authors:  A G Knudson
Journal:  Cancer Res       Date:  1985-04       Impact factor: 12.701

2.  Diversity and rearrangement of the human T cell rearranging gamma genes: nine germ-line variable genes belonging to two subgroups.

Authors:  M P LeFranc; A Forster; R Baer; M A Stinson; T H Rabbitts
Journal:  Cell       Date:  1986-04-25       Impact factor: 41.582

3.  A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs.

Authors:  R A Young; O Hagenbüchle; U Schibler
Journal:  Cell       Date:  1981-02       Impact factor: 41.582

Review 4.  Structure and evolution of calcium-modulated proteins.

Authors:  R H Kretsinger
Journal:  CRC Crit Rev Biochem       Date:  1980

5.  Alternative transcription and two modes of splicing results in two myosin light chains from one gene.

Authors:  Y Nabeshima; Y Fujii-Kuriyama; M Muramatsu; K Ogata
Journal:  Nature       Date:  1984 Mar 22-28       Impact factor: 49.962

6.  Translocation joins c-myc and immunoglobulin gamma 1 genes in a Burkitt lymphoma revealing a third exon in the c-myc oncogene.

Authors:  P H Hamlyn; T H Rabbitts
Journal:  Nature       Date:  1983 Jul 14-20       Impact factor: 49.962

7.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

8.  Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells.

Authors:  C V Hall; P E Jacob; G M Ringold; F Lee
Journal:  J Mol Appl Genet       Date:  1983

9.  Alternating purine-pyrimidine tracts may promote chromosomal translocations seen in a variety of human lymphoid tumours.

Authors:  T Boehm; L Mengle-Gaw; U R Kees; N Spurr; I Lavenir; A Forster; T H Rabbitts
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

10.  Gene transfer into mouse lyoma cells by electroporation in high electric fields.

Authors:  E Neumann; M Schaefer-Ridder; Y Wang; P H Hofschneider
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  18 in total

1.  Differential splicing creates a diversity of transcripts from a neurospecific developmentally regulated gene encoding a protein with new zinc-finger motifs.

Authors:  V L Buchman; N N Ninkina; Y D Bogdanov; A L Bortvin; H N Akopian; S L Kiselev; K V Anokhin; G P Georgiev
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

2.  A simple technique for generating probes for RNA in situ hybridization: an adjunct to genome mapping exemplified by the RAG-1/RAG-2 gene cluster.

Authors:  T Boehm; R Gonzalez-Sarmiento; M Kennedy; T H Rabbitts
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

3.  The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13.

Authors:  T Boehm; L Foroni; Y Kaneko; M F Perutz; T H Rabbitts
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

4.  HOX11, a homeobox-containing T-cell oncogene on human chromosome 10q24.

Authors:  M A Kennedy; R Gonzalez-Sarmiento; U R Kees; F Lampert; N Dear; T Boehm; T H Rabbitts
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

5.  Expression of LIM protein genes Lmo1, Lmo2, and Lmo3 in adult mouse hippocampus and other forebrain regions: differential regulation by seizure activity.

Authors:  G L Hinks; B Shah; S J French; L S Campos; K Staley; J Hughes; M V Sofroniew
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

6.  The LIM region of a presumptive Caenorhabditis elegans transcription factor is an iron-sulfur- and zinc-containing metallodomain.

Authors:  P M Li; J Reichert; G Freyd; H R Horvitz; C T Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

Review 7.  An analysis of vertebrate mRNA sequences: intimations of translational control.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

8.  The mouse homolog of the rhombotin (Ttg-1) gene maps on chromosome 7 distal to the beta-globin (Hbb) locus.

Authors:  J M Angel; J L Moore; A Pelphrey; E R Richie
Journal:  Mamm Genome       Date:  1993       Impact factor: 2.957

9.  Islet expression of Rhombotin and Isl-1 suggests cell type specific exposure of LIM-domain epitopes.

Authors:  K Lund; J S Petersen; J Jensen; N Blume; T Edlund; S Thor; O D Madsen
Journal:  Endocrine       Date:  1995-06       Impact factor: 3.633

10.  Thymic overexpression of Ttg-1 in transgenic mice results in T-cell acute lymphoblastic leukemia/lymphoma.

Authors:  E A McGuire; C E Rintoul; G M Sclar; S J Korsmeyer
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.